Page 2 - புனே அடிப்படையிலானது தேசிய நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புனே அடிப்படையிலானது தேசிய நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புனே அடிப்படையிலானது தேசிய நிறுவனம் Today - Breaking & Trending Today

Less than 10% of vaccinated needed hospitalisation: NIV | India News

MUMBAI/ PUNE: In the largest study done so far in India to understand why people got Covid-19 despite taking one or two vaccine shots, scientists from the Pune-based National Institute of Virology (NIV) found a simple answer: B.1.617.2, that is better known as the Delta variant.
The Delta variant was found in 87% of the 677 throat and nasal swabs of Covid-19 patients from 17 states and union territories. While 592 of these patients had taken two doses, 85 had taken only one dose before getting infected with the SARS2 virus.
The genomic analysis showed the Delta variant’s presence in the majority of the samples, but there also were other variants such as Alpha, Kappa, Delta AY.1 (known as the Delta-plus variant in samples from Madhya Pradesh and Rajasthan) and Delta AY.2. The study, led by director Dr Priya Abraham and senior scientist Dr Pragya Yadav, also found that less than 10% of the 677 patients needed hospitalisation, alluding to the vaccine’s effectiveness in ....

Madhya Pradesh , Priya Abraham , Pragya Yadav , National Institute Of Virology , Pune Based National Institute , மத்யா பிரதேஷ் , பிராகிய யாதவ் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , புனே அடிப்படையிலானது தேசிய நிறுவனம் ,

Vaccine offers 99% protection against death in Delta strain, finds NIV study

Vaccine offers 99% protection against death in Delta strain, finds NIV study
SECTIONS
Share
Synopsis
The genomic analysis carried out as part of the study showed the Delta variant’s presence in the majority of the samples, but there also were other variants such as Alpha, Kappa, Delta AY.1 (known as the Delta-plus variant in samples from MP and Rajasthan) and Delta AY.2.
AP
(This story originally appeared in
on Jul 17, 2021)Scientists from the Pune-based National Institute of Virology (NIV) conducted the largest study done so far in India to understand why people got Covid-19 despite taking one or two vaccine shots. ....

United Kingdom , National Institute Of Virology , Pune Based National Institute , ஒன்றுபட்டது கிஂக்டம் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , புனே அடிப்படையிலானது தேசிய நிறுவனம் ,

87% breakthrough cases test +ve for Delta variant, finds NIV study | Pune News

Representative image
MUMBAI/PUNE: In the largest study done so far in India to understand why people got Covid-19 despite taking one or two vaccine shots, scientists from Pune-based National Institute of Virology (NIV) found a simple answer: B.1.617.2 (Delta variant).
Genomic analysis found Delta in 87% of the 677 throat and nasal swabs of patients from 17 states and UTs. While 592 of them had taken two doses, 85 had taken only one dose before getting infected with the SARS2 virus.
The study, led by director Dr Priya Abraham and senior scientists Dr Pragya Yadav, also found that less than 10% of the 677 patients needed hospitalisation, alluding to the vaccine’s effectiveness in preventing a severe infection. ....

United Kingdom , Priya Abraham , Pragya Yadav , National Institute Of Virology , Pune Based National Institute , ஒன்றுபட்டது கிஂக்டம் , பிராகிய யாதவ் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , புனே அடிப்படையிலானது தேசிய நிறுவனம் ,

Vaccine offers 99% protection against death in Delta strain, finds NIV study | Mumbai News

“This study indicated that a majority of the clinical cases in the breakthrough were infected with the Delta variant and only 9.8% cases required hospitalization, while fatality was observed in only 0.4% cases. This clearly suggests that the vaccination does provide reduction in hospital admission and mortality,” concluded the study.
Most patients in this study were young the median age was 44 (31-56), more were men (65.1%) and 71% of them were symptomatic, with one or more symptoms. Fever (69%) was the most common symptom, followed by bodyache, including headache and nausea (56%), cough (45%) and sore throat (37%).
The researchers said breakthrough Covid-19 infections have been reported from various countries. “It appears the current Covid-19 vaccines are disease-modifying in nature wherein mild or less severe infections are expected to occur in vaccinated individuals,” said the study. Vaccination prevents severe disease, hospitalization and death, as is being ....

United Kingdom , National Institute Of Virology , Pune Based National Institute , ஒன்றுபட்டது கிஂக்டம் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , புனே அடிப்படையிலானது தேசிய நிறுவனம் ,

Covaxin protects against Delta, Beta variants of COVID-19, says study

The Delta variant (B.1.617.2) was first found in India and is the dominant strain in the country, the Beta variant (B.1.351) was first discovered in South Africa. ....

South Africa , Balram Bhargava , Pragya Yadav , National Institute Of Virology , Indian Council Of Medical Research , Pune National Institute Of Virology , Image Source , National Institute , Indian Council , Medical Research , Bharat Biotech , Pune Based National Institute , Study On Covaxin , Delta Variants , Covaxin Protection , India Based Coronavirus Vaccine , Vaccine Protectios Against Beta Variants , Vaccine Protections Against Delta Variants , Neutralisation Titer Values In Covixin , Icmr On Covaxin , Covaxin Vaccine , Covid Vaccine , Ovid 19 Variants , Ovid 1icmr On Covaxin , Covid 19 Mutation , National Institute Of Virology ,